Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. This 55-inch Panasonic Full Array TV has dropped to just £649 at Richer Sounds, making it £550 ...

10x Genomics has a 1 year low of $9.27 and a 1 year high of $44.21. The firm’s fifty day simple moving average is $13.75 and its 200 day simple moving average is $16.55. 10x Genomics (NASDAQ ...

SCOTTS VALLEY, Calif., March 5, 2025 /PRNewswire/ -- Dovetail Genomics, a global leader in Hi-C genomic services, is pleased to announce the inclusion of the Centro Nacional de Análisis ...

10x Genomics has a fifty-two week low of $9.77 and a fifty-two week high of $45.60. The firm’s 50 day moving average price is $13.90 and its 200 day moving average price is $16.67. Get 10x ...

Vancouver, British Columbia--(Newsfile Corp. - February 3, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the "Company" or "Moss") is pleased to announce a non-brokered private placement of up ...

PLEASANTON, Calif., March 3, 2025 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences.

Trisha Bartlett is an Associate Director of Strategic Marketing at 10x Genomics, supporting the Visium and Xenium spatial platforms. She leads marketing efforts for customers across academic and ...

Assets in the region span medtech/medical device development and manufacturing, bioinformatics, genomics, nutrition, human health, clinical research, and, increasingly, biopharma manufacturers.

In 2024, 10x Genomics launched its groundbreaking Visium HD product, increasing the resolution of the Visium platform by over three orders of magnitude. Now compatible with FFPE, Fresh Frozen and ...